3-amino-6-azaniumylidene-9-[2-carboxy-4-(2,2,3-trimethylbutylcarbamoyl)phenyl]xanthene-4,5-disulfonate;[9-[2-carboxy-4-(2,2,3-trimethylbutylcarbamoyl)phenyl]-6-ethyl-2,7-dimethyl-9,9a-dihydroxanthen-3-ylidene]-ethylazanium;2-[(1E,3E,5Z)-5-(1-ethyl-3,3,5-trimethylindol-2-ylidene)penta-1,3-dienyl]-3,3-dimethyl-1-[6-oxo-6-(2,2,3-trimethylbutylamino)hexyl]indol-1-ium-5-sulfonate;bis(2-(3-oxa-23-aza-9-azoniaheptacyclo[17.7.1.15,9.02,17.04,15.023,27.013,28]octacosa-1(27),2(17),4,9(28),13,15,18-heptaen-16-yl)-5-(2,2,3-trimethylbutylcarbamoyl)benzoic acid);[4-[[5-oxo-5-(2,2,3-trimethylbutylamino)pentyl]carbamoyl]phenyl]boronic acid;3-propoxy-N-(2,2,3-trimethylbutyl)propanamide;N-(2,2,3-trimethylbutyl)pentanamide

C227H303BN18O33S3+2 — CID 157300034

About 3-amino-6-azaniumylidene-9-[2-carboxy-4-(2,2,3-trimethylbutylcarbamoyl)phenyl]xanthene-4,5-disulfonate;[9-[2-carboxy-4-(2,2,3-trimethylbutylcarbamoyl)phenyl]-6-ethyl-2,7-dimethyl-9,9a-dihydroxanthen-3-ylidene]-ethylazanium;2-[(1E,3E,5Z)-5-(1-ethyl-3,3,5-trimethylindol-2-ylidene)penta-1,3-dienyl]-3,3-dimethyl-1-[6-oxo-6-(2,2,3-trimethylbutylamino)hexyl]indol-1-ium-5-sulfonate;bis(2-(3-oxa-23-aza-9-azoniaheptacyclo[17.7.1.15,9.02,17.04,15.023,27.013,28]octacosa-1(27),2(17),4,9(28),13,15,18-heptaen-16-yl)-5-(2,2,3-trimethylbutylcarbamoyl)benzoic acid);[4-[[5-oxo-5-(2,2,3-trimethylbutylamino)pentyl]carbamoyl]phenyl]boronic acid;3-propoxy-N-(2,2,3-trimethylbutyl)propanamide;N-(2,2,3-trimethylbutyl)pentanamide

3-amino-6-azaniumylidene-9-[2-carboxy-4-(2,2,3-trimethylbutylcarbamoyl)phenyl]xanthene-4,5-disulfonate;[9-[2-carboxy-4-(2,2,3-trimethylbutylcarbamoyl)phenyl]-6-ethyl-2,7-dimethyl-9,9a-dihydroxanthen-3-ylidene]-ethylazanium;2-[(1E,3E,5Z)-5-(1-ethyl-3,3,5-trimethylindol-2-ylidene)penta-1,3-dienyl]-3,3-dimethyl-1-[6-oxo-6-(2,2,3-trimethylbutylamino)hexyl]indol-1-ium-5-sulfonate;bis(2-(3-oxa-23-aza-9-azoniaheptacyclo[17.7.1.15,9.02,17.04,15.023,27.013,28]octacosa-1(27),2(17),4,9(28),13,15,18-heptaen-16-yl)-5-(2,2,3-trimethylbutylcarbamoyl)benzoic acid);[4-[[5-oxo-5-(2,2,3-trimethylbutylamino)pentyl]carbamoyl]phenyl]boronic acid;3-propoxy-N-(2,2,3-trimethylbutyl)propanamide;N-(2,2,3-trimethylbutyl)pentanamide (PubChem CID 157300034) has the molecular formula C227H303BN18O33S3+2 and a molecular weight of 3919.03 g/mol. Its IUPAC name is 3-amino-6-azaniumylidene-9-[2-carboxy-4-(2,2,3-trimethylbutylcarbamoyl)phenyl]xanthene-4,5-disulfonate;[9-[2-carboxy-4-(2,2,3-trimethylbutylcarbamoyl)phenyl]-6-ethyl-2,7-dimethyl-9,9a-dihydroxanthen-3-ylidene]-ethylazanium;2-[(1E,3E,5Z)-5-(1-ethyl-3,3,5-trimethylindol-2-ylidene)penta-1,3-dienyl]-3,3-dimethyl-1-[6-oxo-6-(2,2,3-trimethylbutylamino)hexyl]indol-1-ium-5-sulfonate;bis(2-(3-oxa-23-aza-9-azoniaheptacyclo[17.7.1.15,9.02,17.04,15.023,27.013,28]octacosa-1(27),2(17),4,9(28),13,15,18-heptaen-16-yl)-5-(2,2,3-trimethylbutylcarbamoyl)benzoic acid);[4-[[5-oxo-5-(2,2,3-trimethylbutylamino)pentyl]carbamoyl]phenyl]boronic acid;3-propoxy-N-(2,2,3-trimethylbutyl)propanamide;N-(2,2,3-trimethylbutyl)pentanamide.

Molecular Properties

• Compound Name: 3-amino-6-azaniumylidene-9-[2-carboxy-4-(2,2,3-trimethylbutylcarbamoyl)phenyl]xanthene-4,5-disulfonate;[9-[2-carboxy-4-(2,2,3-trimethylbutylcarbamoyl)phenyl]-6-ethyl-2,7-dimethyl-9,9a-dihydroxanthen-3-ylidene]-ethylazanium;2-[(1E,3E,5Z)-5-(1-ethyl-3,3,5-trimethylindol-2-ylidene)penta-1,3-dienyl]-3,3-dimethyl-1-[6-oxo-6-(2,2,3-trimethylbutylamino)hexyl]indol-1-ium-5-sulfonate;bis(2-(3-oxa-23-aza-9-azoniaheptacyclo[17.7.1.15,9.02,17.04,15.023,27.013,28]octacosa-1(27),2(17),4,9(28),13,15,18-heptaen-16-yl)-5-(2,2,3-trimethylbutylcarbamoyl)benzoic acid);[4-[[5-oxo-5-(2,2,3-trimethylbutylamino)pentyl]carbamoyl]phenyl]boronic acid;3-propoxy-N-(2,2,3-trimethylbutyl)propanamide;N-(2,2,3-trimethylbutyl)pentanamide
• PubChem CID: 157300034
• Molecular Formula: C227H303BN18O33S3+2
• Molecular Weight: 3919.03 g/mol
• Exact Mass: 3916.18
• IUPAC Name: 3-amino-6-azaniumylidene-9-[2-carboxy-4-(2,2,3-trimethylbutylcarbamoyl)phenyl]xanthene-4,5-disulfonate;[9-[2-carboxy-4-(2,2,3-trimethylbutylcarbamoyl)phenyl]-6-ethyl-2,7-dimethyl-9,9a-dihydroxanthen-3-ylidene]-ethylazanium;2-[(1E,3E,5Z)-5-(1-ethyl-3,3,5-trimethylindol-2-ylidene)penta-1,3-dienyl]-3,3-dimethyl-1-[6-oxo-6-(2,2,3-trimethylbutylamino)hexyl]indol-1-ium-5-sulfonate;bis(2-(3-oxa-23-aza-9-azoniaheptacyclo[17.7.1.15,9.02,17.04,15.023,27.013,28]octacosa-1(27),2(17),4,9(28),13,15,18-heptaen-16-yl)-5-(2,2,3-trimethylbutylcarbamoyl)benzoic acid);[4-[[5-oxo-5-(2,2,3-trimethylbutylamino)pentyl]carbamoyl]phenyl]boronic acid;3-propoxy-N-(2,2,3-trimethylbutyl)propanamide;N-(2,2,3-trimethylbutyl)pentanamide
• SMILES: CC(C)C(C)(C)CNC(=O)CCCCNC(=O)c1ccc(B(O)O)cc1.CC(C)C(C)(C)CNC(=O)c1ccc(-c2c3ccc(=[NH2+])c(S(=O)(=O)[O-])c-3oc3c(S(=O)(=O)[O-])c(N)ccc23)c(C(=O)O)c1.CC(C)C(C)(C)CNC(=O)c1ccc(C2=c3cc4c5c(c3Oc3c2cc2c6c3CCCN6CCC2)CCC[N+]=5CCC4)c(C(=O)O)c1.CC(C)C(C)(C)CNC(=O)c1ccc(C2=c3cc4c5c(c3Oc3c2cc2c6c3CCCN6CCC2)CCC[N+]=5CCC4)c(C(=O)O)c1.CC/[NH+]=C1\C=C2Oc3cc(CC)c(C)cc3C(c3ccc(C(=O)NCC(C)(C)C(C)C)cc3C(=O)O)C2C=C1C.CCCCC(=O)NCC(C)(C)C(C)C.CCCOCCC(=O)NCC(C)(C)C(C)C.CCN1/C(=C\C=C\C=C\C2=[N+](CCCCCC(=O)NCC(C)(C)C(C)C)c3ccc(S(=O)(=O)[O-])cc3C2(C)C)C(C)(C)c2cc(C)ccc21
• InChI: InChI=1S/C41H57N3O4S.2C40H45N3O4.C34H42N2O4.C28H29N3O10S2.C19H31BN2O4.C13H27NO2.C12H25NO/c1-11-43-34-23-21-30(4)26-32(34)40(7,8)36(43)18-14-12-15-19-37-41(9,10)33-27-31(49(46,47)48)22-24-35(33)44(37)25-17-13-16-20-38(45)42-28-39(5,6)29(2)3;2*1-23(2)40(3,4)22-41-38(44)26-13-14-27(30(21-26)39(45)46)33-31-19-24-9-5-15-42-17-7-11-28(34(24)42)36(31)47-37-29-12-8-18-43-16-6-10-25(35(29)43)20-32(33)37;1-9-22-16-29-26(13-20(22)5)31(27-14-21(6)28(35-10-2)17-30(27)40-29)24-12-11-23(15-25(24)33(38)39)32(37)36-18-34(7,8)19(3)4;1-13(2)28(3,4)12-31-26(32)14-5-6-15(18(11-14)27(33)34)21-16-7-9-19(29)24(42(35,36)37)22(16)41-23-17(21)8-10-20(30)25(23)43(38,39)40;1-14(2)19(3,4)13-22-17(23)7-5-6-12-21-18(24)15-8-10-16(11-9-15)20(25)26;1-6-8-16-9-7-12(15)14-10-13(4,5)11(2)3;1-6-7-8-11(14)13-9-12(4,5)10(2)3/h12,14-15,18-19,21-24,26-27,29H,11,13,16-17,20,25,28H2,1-10H3,(H-,42,45,46,47,48);2*13-14,19-21,23H,5-12,15-18,22H2,1-4H3,(H-,41,44,45,46);11-17,19,27,31H,9-10,18H2,1-8H3,(H,36,37)(H,38,39);5-11,13,29H,12,30H2,1-4H3,(H,31,32)(H,33,34)(H,35,36,37)(H,38,39,40);8-11,14,25-26H,5-7,12-13H2,1-4H3,(H,21,24)(H,22,23);11H,6-10H2,1-5H3,(H,14,15);10H,6-9H2,1-5H3,(H,13,14)/p+2/b;;;35-28+
• InChIKey: BBUDKPNNCKJVJU-JUZJMGQUSA-P
• XLogP: 32.11
• TPSA: 757.55 Ų
• H-Bond Donors: 18
• H-Bond Acceptors: 33
• Rotatable Bonds: 66
• Heavy Atoms: 282
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	3919.03
LogP ≤ 5	32.11
H-Bond Donors ≤ 5	18
H-Bond Acceptors ≤ 10	33

Frequently Asked Questions

What is the IUPAC name of 3-amino-6-azaniumylidene-9-[2-carboxy-4-(2,2,3-trimethylbutylcarbamoyl)phenyl]xanthene-4,5-disulfonate;[9-[2-carboxy-4-(2,2,3-trimethylbutylcarbamoyl)phenyl]-6-ethyl-2,7-dimethyl-9,9a-dihydroxanthen-3-ylidene]-ethylazanium;2-[(1E,3E,5Z)-5-(1-ethyl-3,3,5-trimethylindol-2-ylidene)penta-1,3-dienyl]-3,3-dimethyl-1-[6-oxo-6-(2,2,3-trimethylbutylamino)hexyl]indol-1-ium-5-sulfonate;bis(2-(3-oxa-23-aza-9-azoniaheptacyclo[17.7.1.15,9.02,17.04,15.023,27.013,28]octacosa-1(27),2(17),4,9(28),13,15,18-heptaen-16-yl)-5-(2,2,3-trimethylbutylcarbamoyl)benzoic acid);[4-[[5-oxo-5-(2,2,3-trimethylbutylamino)pentyl]carbamoyl]phenyl]boronic acid;3-propoxy-N-(2,2,3-trimethylbutyl)propanamide;N-(2,2,3-trimethylbutyl)pentanamide?

The IUPAC name of 3-amino-6-azaniumylidene-9-[2-carboxy-4-(2,2,3-trimethylbutylcarbamoyl)phenyl]xanthene-4,5-disulfonate;[9-[2-carboxy-4-(2,2,3-trimethylbutylcarbamoyl)phenyl]-6-ethyl-2,7-dimethyl-9,9a-dihydroxanthen-3-ylidene]-ethylazanium;2-[(1E,3E,5Z)-5-(1-ethyl-3,3,5-trimethylindol-2-ylidene)penta-1,3-dienyl]-3,3-dimethyl-1-[6-oxo-6-(2,2,3-trimethylbutylamino)hexyl]indol-1-ium-5-sulfonate;bis(2-(3-oxa-23-aza-9-azoniaheptacyclo[17.7.1.15,9.02,17.04,15.023,27.013,28]octacosa-1(27),2(17),4,9(28),13,15,18-heptaen-16-yl)-5-(2,2,3-trimethylbutylcarbamoyl)benzoic acid);[4-[[5-oxo-5-(2,2,3-trimethylbutylamino)pentyl]carbamoyl]phenyl]boronic acid;3-propoxy-N-(2,2,3-trimethylbutyl)propanamide;N-(2,2,3-trimethylbutyl)pentanamide (CID 157300034) is 3-amino-6-azaniumylidene-9-[2-carboxy-4-(2,2,3-trimethylbutylcarbamoyl)phenyl]xanthene-4,5-disulfonate;[9-[2-carboxy-4-(2,2,3-trimethylbutylcarbamoyl)phenyl]-6-ethyl-2,7-dimethyl-9,9a-dihydroxanthen-3-ylidene]-ethylazanium;2-[(1E,3E,5Z)-5-(1-ethyl-3,3,5-trimethylindol-2-ylidene)penta-1,3-dienyl]-3,3-dimethyl-1-[6-oxo-6-(2,2,3-trimethylbutylamino)hexyl]indol-1-ium-5-sulfonate;bis(2-(3-oxa-23-aza-9-azoniaheptacyclo[17.7.1.15,9.02,17.04,15.023,27.013,28]octacosa-1(27),2(17),4,9(28),13,15,18-heptaen-16-yl)-5-(2,2,3-trimethylbutylcarbamoyl)benzoic acid);[4-[[5-oxo-5-(2,2,3-trimethylbutylamino)pentyl]carbamoyl]phenyl]boronic acid;3-propoxy-N-(2,2,3-trimethylbutyl)propanamide;N-(2,2,3-trimethylbutyl)pentanamide.

What is the SMILES notation for 3-amino-6-azaniumylidene-9-[2-carboxy-4-(2,2,3-trimethylbutylcarbamoyl)phenyl]xanthene-4,5-disulfonate;[9-[2-carboxy-4-(2,2,3-trimethylbutylcarbamoyl)phenyl]-6-ethyl-2,7-dimethyl-9,9a-dihydroxanthen-3-ylidene]-ethylazanium;2-[(1E,3E,5Z)-5-(1-ethyl-3,3,5-trimethylindol-2-ylidene)penta-1,3-dienyl]-3,3-dimethyl-1-[6-oxo-6-(2,2,3-trimethylbutylamino)hexyl]indol-1-ium-5-sulfonate;bis(2-(3-oxa-23-aza-9-azoniaheptacyclo[17.7.1.15,9.02,17.04,15.023,27.013,28]octacosa-1(27),2(17),4,9(28),13,15,18-heptaen-16-yl)-5-(2,2,3-trimethylbutylcarbamoyl)benzoic acid);[4-[[5-oxo-5-(2,2,3-trimethylbutylamino)pentyl]carbamoyl]phenyl]boronic acid;3-propoxy-N-(2,2,3-trimethylbutyl)propanamide;N-(2,2,3-trimethylbutyl)pentanamide?

The canonical SMILES for 3-amino-6-azaniumylidene-9-[2-carboxy-4-(2,2,3-trimethylbutylcarbamoyl)phenyl]xanthene-4,5-disulfonate;[9-[2-carboxy-4-(2,2,3-trimethylbutylcarbamoyl)phenyl]-6-ethyl-2,7-dimethyl-9,9a-dihydroxanthen-3-ylidene]-ethylazanium;2-[(1E,3E,5Z)-5-(1-ethyl-3,3,5-trimethylindol-2-ylidene)penta-1,3-dienyl]-3,3-dimethyl-1-[6-oxo-6-(2,2,3-trimethylbutylamino)hexyl]indol-1-ium-5-sulfonate;bis(2-(3-oxa-23-aza-9-azoniaheptacyclo[17.7.1.15,9.02,17.04,15.023,27.013,28]octacosa-1(27),2(17),4,9(28),13,15,18-heptaen-16-yl)-5-(2,2,3-trimethylbutylcarbamoyl)benzoic acid);[4-[[5-oxo-5-(2,2,3-trimethylbutylamino)pentyl]carbamoyl]phenyl]boronic acid;3-propoxy-N-(2,2,3-trimethylbutyl)propanamide;N-(2,2,3-trimethylbutyl)pentanamide is CC(C)C(C)(C)CNC(=O)CCCCNC(=O)c1ccc(B(O)O)cc1.CC(C)C(C)(C)CNC(=O)c1ccc(-c2c3ccc(=[NH2+])c(S(=O)(=O)[O-])c-3oc3c(S(=O)(=O)[O-])c(N)ccc23)c(C(=O)O)c1.CC(C)C(C)(C)CNC(=O)c1ccc(C2=c3cc4c5c(c3Oc3c2cc2c6c3CCCN6CCC2)CCC[N+]=5CCC4)c(C(=O)O)c1.CC(C)C(C)(C)CNC(=O)c1ccc(C2=c3cc4c5c(c3Oc3c2cc2c6c3CCCN6CCC2)CCC[N+]=5CCC4)c(C(=O)O)c1.CC/[NH+]=C1\C=C2Oc3cc(CC)c(C)cc3C(c3ccc(C(=O)NCC(C)(C)C(C)C)cc3C(=O)O)C2C=C1C.CCCCC(=O)NCC(C)(C)C(C)C.CCCOCCC(=O)NCC(C)(C)C(C)C.CCN1/C(=C\C=C\C=C\C2=[N+](CCCCCC(=O)NCC(C)(C)C(C)C)c3ccc(S(=O)(=O)[O-])cc3C2(C)C)C(C)(C)c2cc(C)ccc21.

What is the InChIKey of 3-amino-6-azaniumylidene-9-[2-carboxy-4-(2,2,3-trimethylbutylcarbamoyl)phenyl]xanthene-4,5-disulfonate;[9-[2-carboxy-4-(2,2,3-trimethylbutylcarbamoyl)phenyl]-6-ethyl-2,7-dimethyl-9,9a-dihydroxanthen-3-ylidene]-ethylazanium;2-[(1E,3E,5Z)-5-(1-ethyl-3,3,5-trimethylindol-2-ylidene)penta-1,3-dienyl]-3,3-dimethyl-1-[6-oxo-6-(2,2,3-trimethylbutylamino)hexyl]indol-1-ium-5-sulfonate;bis(2-(3-oxa-23-aza-9-azoniaheptacyclo[17.7.1.15,9.02,17.04,15.023,27.013,28]octacosa-1(27),2(17),4,9(28),13,15,18-heptaen-16-yl)-5-(2,2,3-trimethylbutylcarbamoyl)benzoic acid);[4-[[5-oxo-5-(2,2,3-trimethylbutylamino)pentyl]carbamoyl]phenyl]boronic acid;3-propoxy-N-(2,2,3-trimethylbutyl)propanamide;N-(2,2,3-trimethylbutyl)pentanamide?

The InChIKey is BBUDKPNNCKJVJU-JUZJMGQUSA-P. The full InChI is InChI=1S/C41H57N3O4S.2C40H45N3O4.C34H42N2O4.C28H29N3O10S2.C19H31BN2O4.C13H27NO2.C12H25NO/c1-11-43-34-23-21-30(4)26-32(34)40(7,8)36(43)18-14-12-15-19-37-41(9,10)33-27-31(49(46,47)48)22-24-35(33)44(37)25-17-13-16-20-38(45)42-28-39(5,6)29(2)3;2*1-23(2)40(3,4)22-41-38(44)26-13-14-27(30(21-26)39(45)46)33-31-19-24-9-5-15-42-17-7-11-28(34(24)42)36(31)47-37-29-12-8-18-43-16-6-10-25(35(29)43)20-32(33)37;1-9-22-16-29-26(13-20(22)5)31(27-14-21(6)28(35-10-2)17-30(27)40-29)24-12-11-23(15-25(24)33(38)39)32(37)36-18-34(7,8)19(3)4;1-13(2)28(3,4)12-31-26(32)14-5-6-15(18(11-14)27(33)34)21-16-7-9-19(29)24(42(35,36)37)22(16)41-23-17(21)8-10-20(30)25(23)43(38,39)40;1-14(2)19(3,4)13-22-17(23)7-5-6-12-21-18(24)15-8-10-16(11-9-15)20(25)26;1-6-8-16-9-7-12(15)14-10-13(4,5)11(2)3;1-6-7-8-11(14)13-9-12(4,5)10(2)3/h12,14-15,18-19,21-24,26-27,29H,11,13,16-17,20,25,28H2,1-10H3,(H-,42,45,46,47,48);2*13-14,19-21,23H,5-12,15-18,22H2,1-4H3,(H-,41,44,45,46);11-17,19,27,31H,9-10,18H2,1-8H3,(H,36,37)(H,38,39);5-11,13,29H,12,30H2,1-4H3,(H,31,32)(H,33,34)(H,35,36,37)(H,38,39,40);8-11,14,25-26H,5-7,12-13H2,1-4H3,(H,21,24)(H,22,23);11H,6-10H2,1-5H3,(H,14,15);10H,6-9H2,1-5H3,(H,13,14)/p+2/b;;;35-28+;;;;.

What are the key properties of 3-amino-6-azaniumylidene-9-[2-carboxy-4-(2,2,3-trimethylbutylcarbamoyl)phenyl]xanthene-4,5-disulfonate;[9-[2-carboxy-4-(2,2,3-trimethylbutylcarbamoyl)phenyl]-6-ethyl-2,7-dimethyl-9,9a-dihydroxanthen-3-ylidene]-ethylazanium;2-[(1E,3E,5Z)-5-(1-ethyl-3,3,5-trimethylindol-2-ylidene)penta-1,3-dienyl]-3,3-dimethyl-1-[6-oxo-6-(2,2,3-trimethylbutylamino)hexyl]indol-1-ium-5-sulfonate;bis(2-(3-oxa-23-aza-9-azoniaheptacyclo[17.7.1.15,9.02,17.04,15.023,27.013,28]octacosa-1(27),2(17),4,9(28),13,15,18-heptaen-16-yl)-5-(2,2,3-trimethylbutylcarbamoyl)benzoic acid);[4-[[5-oxo-5-(2,2,3-trimethylbutylamino)pentyl]carbamoyl]phenyl]boronic acid;3-propoxy-N-(2,2,3-trimethylbutyl)propanamide;N-(2,2,3-trimethylbutyl)pentanamide?

3-amino-6-azaniumylidene-9-[2-carboxy-4-(2,2,3-trimethylbutylcarbamoyl)phenyl]xanthene-4,5-disulfonate;[9-[2-carboxy-4-(2,2,3-trimethylbutylcarbamoyl)phenyl]-6-ethyl-2,7-dimethyl-9,9a-dihydroxanthen-3-ylidene]-ethylazanium;2-[(1E,3E,5Z)-5-(1-ethyl-3,3,5-trimethylindol-2-ylidene)penta-1,3-dienyl]-3,3-dimethyl-1-[6-oxo-6-(2,2,3-trimethylbutylamino)hexyl]indol-1-ium-5-sulfonate;bis(2-(3-oxa-23-aza-9-azoniaheptacyclo[17.7.1.15,9.02,17.04,15.023,27.013,28]octacosa-1(27),2(17),4,9(28),13,15,18-heptaen-16-yl)-5-(2,2,3-trimethylbutylcarbamoyl)benzoic acid);[4-[[5-oxo-5-(2,2,3-trimethylbutylamino)pentyl]carbamoyl]phenyl]boronic acid;3-propoxy-N-(2,2,3-trimethylbutyl)propanamide;N-(2,2,3-trimethylbutyl)pentanamide has a molecular weight of 3919.03 g/mol, XLogP of 32.11, 66 rotatable bonds, 18 hydrogen bond donors, and 33 hydrogen bond acceptors.

Where does this data come from?

All data for 3-amino-6-azaniumylidene-9-[2-carboxy-4-(2,2,3-trimethylbutylcarbamoyl)phenyl]xanthene-4,5-disulfonate;[9-[2-carboxy-4-(2,2,3-trimethylbutylcarbamoyl)phenyl]-6-ethyl-2,7-dimethyl-9,9a-dihydroxanthen-3-ylidene]-ethylazanium;2-[(1E,3E,5Z)-5-(1-ethyl-3,3,5-trimethylindol-2-ylidene)penta-1,3-dienyl]-3,3-dimethyl-1-[6-oxo-6-(2,2,3-trimethylbutylamino)hexyl]indol-1-ium-5-sulfonate;bis(2-(3-oxa-23-aza-9-azoniaheptacyclo[17.7.1.15,9.02,17.04,15.023,27.013,28]octacosa-1(27),2(17),4,9(28),13,15,18-heptaen-16-yl)-5-(2,2,3-trimethylbutylcarbamoyl)benzoic acid);[4-[[5-oxo-5-(2,2,3-trimethylbutylamino)pentyl]carbamoyl]phenyl]boronic acid;3-propoxy-N-(2,2,3-trimethylbutyl)propanamide;N-(2,2,3-trimethylbutyl)pentanamide is sourced from PubChem (CID 157300034), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).